Lifting of Force Majeure on Methacrylate Monomers

The Force Majeure on the sale of Methacrylate Monomers was lifted on Thursday 26th February (see previous entry for further information) and replaced by a sales control process while we manage a return to normal levels of service. We sincerely apologise for the disruption in service and any inconvenience arising from this interruption. We would […]

Continue reading »

Developing bio routes to MMA

To enter biotechnological processes or not? What factors need to be considered? How does a chemical company select the best manufacturing route once it has entered the biotechnology arena? These are some of the questions Dr David Johnson, Research Associate and Technical Leader of Biotechnology Process Development at Lucite International (LI), has considered this week […]

Continue reading »

Interruption to the supply of methacrylate monomers

Lucite regrettably encountered a technical issue at the Cassel Site in the UK which meant that we had no option but to declare Force Majeure, as of Monday 9th February, on sales of methacrylate monomers manufactured at the site. At this time we are in the process of resolving the technical issue and attempting to source […]

Continue reading »

Cassel achieves ISO50001 energy certification

We are delighted to announce that the Cassel Site has gained certification to the International Energy Management System Standard ISO50001, following a successful assessment carried out by accredited auditor LRQA . An energy improvement plan has been produced that will enable the site to meet the company sustainability improvement targets to reduce energy and CO2 […]

Continue reading »